Vuillermoz Alice, Lefranc Mathilde, Prouvez Nathan, Brault Clément, Zerbib Yoann, Schmitt Mary, Forel Jean-Marie, Le Tutour Mathieu, Lesimple Arnaud, Mercat Alain, Richard Jean-Christophe, Beloncle François M
Vent'Lab, Medical Intensive Care Unit, University Hospital of Angers, Angers, France.
University of Angers, Angers, France.
Ann Intensive Care. 2024 Aug 21;14(1):130. doi: 10.1186/s13613-024-01351-w.
Nitric oxide (NO) is a strong vasodilator, selectively directed on pulmonary circulation through inhaled administration. In adult intensive care units (ICU), it is mainly used for refractory hypoxemia in mechanically ventilated patients. Several medical delivery devices have been developed to deliver inhaled nitric oxide (iNO). The main purpose of those devices is to guarantee an accurate inspiratory NO concentration, whatever the ventilator used, with NO concentrations lower than 0.3 ppm. We hypothesized that the performances of the different available iNO delivery systems could depend on their working principle and could be influenced by the ventilator settings. The objective of this study was to assess the accuracy of seven different iNO-devices combined with different ICU ventilators' flow-by to reach inspiratory NO concentration targets and to evaluate their potential risk of toxicity.
We tested seven iNO-devices on a test-lung connected to distinct ICU ventilators offering four different levels of flow-by. We measured the flow in the inspiratory limb of the patient circuit and the airway pressure. The nitric oxide/nitrogen (NO/N) flow was measured on the administration line of the iNO-devices. NO and NO concentrations were measured in the test-lung using an electrochemical analyzer.
We identified three iNO-device generations based on the way they deliver NO flow: "Continuous", "Sequential to inspiratory phase" (I-Sequential) and "Proportional to inspiratory and expiratory ventilator flow" (Proportional). Median accuracy of iNO concentration measured in the test lung was 2% (interquartile range, IQR -19; 36), -23% (IQR -29; -17) and 0% (IQR -2; 0) with Continuous, I-Sequential and Proportional devices, respectively. Increased ventilator flow-by resulted in decreased iNO concentration in the test-lung with Continuous and I-Sequential devices, but not with Proportional ones. NO formation measured to assess potential risks of toxicity never exceeded the predefined safety target of 0.5 ppm. However, NO concentrations higher than or equal to 0.3 ppm, a concentration that can cause bronchoconstriction, were observed in 19% of the different configurations.
We identified three different generations of iNO-devices, based on their gas administration modalities, that were associated with highly variable iNO concentrations' accuracy. Ventilator's flow by significantly impacted iNO concentration. Only the Proportional devices permitted to accurately deliver iNO whatever the conditions and the ventilators tested.
一氧化氮(NO)是一种强效血管扩张剂,通过吸入给药可选择性作用于肺循环。在成人重症监护病房(ICU)中,它主要用于机械通气患者的难治性低氧血症。已经开发了几种医疗输送设备来输送吸入一氧化氮(iNO)。这些设备的主要目的是无论使用何种呼吸机,都能保证准确的吸入NO浓度,且NO浓度低于0.3 ppm。我们假设不同的现有iNO输送系统的性能可能取决于其工作原理,并可能受到呼吸机设置的影响。本研究的目的是评估七种不同的iNO设备与不同ICU呼吸机的旁通气流相结合时达到吸入NO浓度目标的准确性,并评估其潜在的毒性风险。
我们在连接到提供四种不同旁通气流水平的不同ICU呼吸机的测试肺上测试了七种iNO设备。我们测量了患者回路吸气支的气流和气道压力。在iNO设备的给药管路上测量一氧化氮/氮气(NO/N)气流。使用电化学分析仪在测试肺中测量NO和NO浓度。
根据输送NO气流的方式,我们确定了三代iNO设备:“连续式”、“吸气相顺序式”(I-顺序式)和“与吸气和呼气呼吸机气流成比例式”(比例式)。在测试肺中测量的iNO浓度的中位数准确性在连续式、I-顺序式和比例式设备中分别为2%(四分位间距,IQR -19;36)、-23%(IQR -29;-17)和0%(IQR -2;0)。对于连续式和I-顺序式设备,增加呼吸机旁通气流会导致测试肺中iNO浓度降低,但比例式设备不会。为评估潜在毒性风险而测量的NO生成从未超过预定义的0.5 ppm安全目标。然而,在19%的不同配置中观察到NO浓度高于或等于0.3 ppm,该浓度可导致支气管收缩。
根据气体给药方式,我们确定了三代不同的iNO设备,它们与iNO浓度的准确性高度可变相关。呼吸机的旁通气流对iNO浓度有显著影响。只有比例式设备无论在何种条件和测试的呼吸机下都能准确输送iNO。